Drug Approval | September 30, 2024
USFDA completes inspection at Biocon Biologics’ Insulins facility at Malaysia
The inspection concluded with the issuance of a form 483 with five observations
The inspection concluded with the issuance of a form 483 with five observations
The net-zero target approval complements the company's near-term emission reduction targets
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
India has taken the lead in recognising NAFLD as a major non-communicable disease
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
Pfizer's decision is based on the totality of clinical data
Subscribe To Our Newsletter & Stay Updated
